Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) EBIT (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted EBIT of $2.54 billion for Q3 2026, down 18.6% from $3.11 billion a year earlier and down 37.9% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) EBIT (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBIT at Bristol Myers Squibb was $11.33 billion, up 41.1% year-over-year; for FY2025, it came in at $9.33 billion.

  • In prior years, Bristol Myers Squibb's EBIT was -$8.38 billion in FY2024, $8.44 billion in FY2023 (+9.4%), $7.71 billion in FY2022 (-4.8%) and $8.1 billion in FY2021.
  • Quarterly EBIT has run from a low of -$11.52 billion in Q1 2024 to a high of $4.09 billion in Q2 2026 over five years.
  • On a year-over-year basis, EBIT increased in five of the last seven quarters, with growth averaging 127.9%.
  • The strongest year-over-year quarter for EBIT in the past five years was Q4 2025, with growth of 740.0%; the weakest was Q4 2024, with a decline of 89.5%.
  • According to Business Quant data, EBIT for the three prior quarters was $4.09 billion (Q2 2026), $3.24 billion (Q1 2026) and $1.47 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 6.18 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.27 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.39 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 3.46 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.47 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 2.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.54 Bn
Jun 30, 2026 4.09 Bn
Mar 31, 2026 3.24 Bn
Dec 31, 2025 1.47 Bn
Sep 30, 2025 3.11 Bn
Jun 30, 2025 1.77 Bn
Mar 31, 2025 2.97 Bn
Dec 31, 2024 175.00 Mn
Sep 30, 2024 1.68 Bn
Jun 30, 2024 1.29 Bn
Mar 31, 2024 -11.52 Bn
Dec 31, 2023 1.67 Bn
Sep 30, 2023 2.14 Bn
Jun 30, 2023 1.86 Bn
Mar 31, 2023 2.77 Bn
Dec 31, 2022 1.86 Bn
Sep 30, 2022 2.21 Bn
Jun 30, 2022 1.96 Bn
Mar 31, 2022 1.69 Bn
Dec 31, 2021 1.86 Bn
API Access

Bristol Myers Squibb EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=BMY&period=max&api_key=YOUR_API_KEY